WOS: 000346058800009PubMed: 24853683Cannabidiol (CBD) is a nonpsychoactive phytocannabinoid with anti-inflammatory activity mediated by enhancing adenosine signaling. As the adenosine A(1) receptor activation confers protection against ischemia/reperfusion (I/R)-induced ventricular arrhythmias, we hypothesized that CBD may have antiarrhythmic effect through the activation of adenosine A(1) receptor. Cannabidiol has recently been shown to suppress ischemia-induced ventricular arrhythmias. We aimed to research the effect of CBD on the incidence and the duration of I/R-induced ventricular arrhythmias and to investigate the role of adenosine A(1) receptor activation in the possible antiarrhythmic effect of CBD. Myocardial ischemia and reperfusi...
Anthracyclines such as doxorubicin are effective chemotherapy agents, however a severe and common si...
Background: Cannabinoid type 2 (CB2) receptor agonists can protect myocardium against ischemia/reper...
Preventive treatment with cannabinoid agonists has been reported to reduce the infarct size in a mou...
Cannabidiol (CBD) is a nonpsychoactive phytocannabinoid with anti-inflammatory activity mediated by ...
Cannabinoid receptor activation has been demonstrated to improve myocardial recovery and reduce arrh...
Stimulation of cardiac β-adrenoceptors is the primary mechanism by which cardiac output is incr...
A large number of cannabinoids have been discovered that could play a role in mitigating cardiac aff...
Cannabinoids can mimic the infarct-reducing effect of early ischemic preconditioning, delayed ischem...
Cannabidiol (CBD), the most extensively studied non-intoxicating phytocannabinoid, has been attracti...
This thesis describes work carried out to characterise cardiac responses to cannabinoids. A particul...
Cannabidiol (CBD) has anti-inflammatory effects. We explored its therapeutic effects on cardiac isch...
This thesis describes work carried out to characterise cardiac responses to cannabinoids. A particul...
Preventive treatment with cannabinoid agonists has been reported to reduce the infarct size in a mou...
Synthetic cannabinoids (SCBs) are widely used recreational substances especially among adults. Altho...
Cannabidiol (CBD), the most extensively studied non-intoxicating phytocannabinoid, has been attracti...
Anthracyclines such as doxorubicin are effective chemotherapy agents, however a severe and common si...
Background: Cannabinoid type 2 (CB2) receptor agonists can protect myocardium against ischemia/reper...
Preventive treatment with cannabinoid agonists has been reported to reduce the infarct size in a mou...
Cannabidiol (CBD) is a nonpsychoactive phytocannabinoid with anti-inflammatory activity mediated by ...
Cannabinoid receptor activation has been demonstrated to improve myocardial recovery and reduce arrh...
Stimulation of cardiac β-adrenoceptors is the primary mechanism by which cardiac output is incr...
A large number of cannabinoids have been discovered that could play a role in mitigating cardiac aff...
Cannabinoids can mimic the infarct-reducing effect of early ischemic preconditioning, delayed ischem...
Cannabidiol (CBD), the most extensively studied non-intoxicating phytocannabinoid, has been attracti...
This thesis describes work carried out to characterise cardiac responses to cannabinoids. A particul...
Cannabidiol (CBD) has anti-inflammatory effects. We explored its therapeutic effects on cardiac isch...
This thesis describes work carried out to characterise cardiac responses to cannabinoids. A particul...
Preventive treatment with cannabinoid agonists has been reported to reduce the infarct size in a mou...
Synthetic cannabinoids (SCBs) are widely used recreational substances especially among adults. Altho...
Cannabidiol (CBD), the most extensively studied non-intoxicating phytocannabinoid, has been attracti...
Anthracyclines such as doxorubicin are effective chemotherapy agents, however a severe and common si...
Background: Cannabinoid type 2 (CB2) receptor agonists can protect myocardium against ischemia/reper...
Preventive treatment with cannabinoid agonists has been reported to reduce the infarct size in a mou...